» Authors » K Takenaka

K Takenaka

Explore the profile of K Takenaka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 468
Citations 3731
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shima T, Iwasaki H, Yamauchi T, Kadowaki M, Kiyosuke M, Mochimaru T, et al.
Bone Marrow Transplant . 2015 Jun; 50(9):1195-200. PMID: 26098951
PBSC products for auto- and allografting can be cryopreserved in liquid nitrogen with controlled-rate freezing until their use. Alternatively, they can be stored at -80 °C in a mechanical chest...
2.
Sugai S, Takayanagi Y, Hayamizu N, Muroi T, Shiozaki R, Nohara J, et al.
J Phys Condens Matter . 2013 Oct; 25(47):475701. PMID: 24166932
Fully absorption coefficient corrected Raman spectra were obtained in La2-xSrxCuO4. The B1g spectra have a Fleury-Loudon type two-magnon peak (resonant term) whose energy decreases from 3180 cm(-1) (394 meV) to...
3.
Sugai S, Nohara J, Shiozaki R, Muroi T, Takayanagi Y, Hayamizu N, et al.
J Phys Condens Matter . 2013 Sep; 25(41):415701. PMID: 24055839
In a strongly correlated electron system, the single-particle spectral function changes into a coherent peak and incoherent humps which extend over 1 eV. The incoherent parts lose the symmetry and...
4.
Shimoji S, Kato K, Eriguchi Y, Takenaka K, Iwasaki H, Miyamoto T, et al.
Bone Marrow Transplant . 2013 Jun; 48(9):1249-52. PMID: 23749110
Cord colitis syndrome (CCS) is a recently proposed clinical entity characterized by a persistent diarrheal illness after cord blood transplantation (CBT), which is not caused by GVHD or CMV colitis....
5.
Shima T, Forraz N, Sato N, Yamauchi T, Iwasaki H, Takenaka K, et al.
Int J Lab Hematol . 2012 Dec; 35(4):436-46. PMID: 23241085
Introduction: Cord blood (CB) is being increasingly used as a source of hematopoietic stem cells for transplantation to treat diseases of the blood and immune systems, and there is an...
6.
Chiba N, Takenaka K, Nagata K, Ogawa E, Miyake M
Kyobu Geka . 2012 May; 65(5):401-4. PMID: 22569500
We report 2 patients with lung cancer accompanied by active pulmonary tuberculosis. Case1 was a 82-year-old woman with stage I A bronchioloalveolar carcinoma and tuberculosis in right upper lobe. Right...
7.
Mori Y, Teshima T, Kamezaki K, Kato K, Takenaka K, Iwasaki H, et al.
Bone Marrow Transplant . 2011 Nov; 47(8):1075-81. PMID: 22101199
The Pretransplantation Assessment of Mortality (PAM) score is a risk score for mortality after allogeneic hematopoietic SCT (HSCT). Ethnicity is a genetically determined factor that correlated with immune-mediated outcomes of...
8.
Nishizaki T, Takenaka K, Yanaga K, Kishikawa K, Maehara Y, Shimada M, et al.
Int J Oncol . 2011 May; 8(6):1059-62. PMID: 21544464
Multidrug resistance is a major obstacle to the successful chemotherapy for human cancers. The chemosensitivities of hepatocellular carcinoma (HCC) treated with preoperative lipiodolization (LPD) to anticancer agents were compared to...
9.
Bhobe P, Chainani A, Taguchi M, Takeuchi T, Eguchi R, Matsunami M, et al.
Phys Rev Lett . 2010 Sep; 104(23):236404. PMID: 20867257
We investigate the electronic structure of chromium nitride (CrN) across the first-order magnetostructural transition at T(N)∼286  K. Resonant photoemission spectroscopy (PES) shows a gap in the 3d partial density of...
10.
Iejima D, Minegishi Y, Takenaka K, Siswanto A, Watanabe M, Huang L, et al.
Oncogene . 2010 Mar; 29(21):3087-99. PMID: 20228838
An adaptor protein FRS2beta inhibits epidermal growth factor-receptor (EGFR) tyrosine kinase without being phosphorylated at tyrosine residues after EGF stimulation. Although binding to ERK appears to be important for this...